Publisher Correction: Global absence and targeting of protective immune states in severe COVID-19

doi:10.1038/s41586-021-03718-6

Published Erratum

. 2021 Aug;596(7872):E8.

doi: 10.1038/s41586-021-03718-6.

Publisher Correction: Global absence and targeting of protective immune states in severe COVID-19

Alexis J Combes^#^{1

2

3}, Tristan Courau^#^{4

5

6}, Nicholas F Kuhn^#^{4

5}, Kenneth H Hu^#^{4

5}, Arja Ray^#^{4

5}, William S Chen^{5

7}, Nayvin W Chew^{4

5

6}, Simon J Cleary^{5

8

9}, Divyashree Kushnoor^{4

5

6}, Gabriella C Reeder^{4

5

6}, Alan Shen^{4

5

6}, Jessica Tsui^{4

5

6}, Kamir J Hiam-Galvez^{5

10

11}, Priscila Muñoz-Sandoval^{5

11

12}, Wandi S Zhu^{5

11

12}, David S Lee^{5

13

14}, Yang Sun^{5

13

14}, Ran You^{4

5}, Mélia Magnen^{5

8

9}, Lauren Rodriguez^{5

10}, K W Im^{4

5

6}, Nina K Serwas^{4

5}, Aleksandra Leligdowicz^{8

9}, Colin R Zamecnik^{5

15}, Rita P Loudermilk^{5

15}, Michael R Wilson^{5

15}, Chun J Ye^{5

13

14}, Gabriela K Fragiadakis^{5

6

13

14}, Mark R Looney^{5

8

9}, Vincent Chan^{4

5}, Alyssa Ward^{13

14}, Sidney Carrillo^{8

9}; UCSF COMET Consortium; Michael Matthay^{8

9}, David J Erle^{5

6

8

9}, Prescott G Woodruff^{5

8

9}, Charles Langelier¹⁶, Kirsten Kangelaris¹⁷, Carolyn M Hendrickson^{8

9}, Carolyn Calfee^{8

9}, Arjun Arkal Rao^{18

19

20}, Matthew F Krummel^{21

22}

Collaborators, Affiliations

Collaborators

Affiliations

¹ Department of Pathology, University of California San Francisco, San Francisco, CA, USA. Alexis.Combes@ucsf.edu.
² ImmunoX Initiative, University of California San Francisco, San Francisco, CA, USA. Alexis.Combes@ucsf.edu.
³ UCSF CoLabs, University of California San Francisco, San Francisco, CA, USA. Alexis.Combes@ucsf.edu.
⁴ Department of Pathology, University of California San Francisco, San Francisco, CA, USA.
⁵ ImmunoX Initiative, University of California San Francisco, San Francisco, CA, USA.
⁶ UCSF CoLabs, University of California San Francisco, San Francisco, CA, USA.
⁷ Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
⁸ Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
⁹ Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.
¹⁰ Department of Otolaryngology, University of California San Francisco, San Francisco, CA, USA.
¹¹ Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.
¹² Sandler Asthma Basic Research Center, University of California San Francisco, San Francisco, CA, USA.
¹³ Institute for Human Genetics, University of California San Francisco, San Francisco, CA, USA.
¹⁴ Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
¹⁵ Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
¹⁶ Division of Infectious Disease, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
¹⁷ Division of Hospital Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
¹⁸ Department of Pathology, University of California San Francisco, San Francisco, CA, USA. ArjunArkal.Rao@ucsf.edu.
¹⁹ ImmunoX Initiative, University of California San Francisco, San Francisco, CA, USA. ArjunArkal.Rao@ucsf.edu.
²⁰ UCSF CoLabs, University of California San Francisco, San Francisco, CA, USA. ArjunArkal.Rao@ucsf.edu.
²¹ Department of Pathology, University of California San Francisco, San Francisco, CA, USA. Matthew.Krummel@ucsf.edu.
²² ImmunoX Initiative, University of California San Francisco, San Francisco, CA, USA. Matthew.Krummel@ucsf.edu.

^# Contributed equally.

PMID: 34341540
PMCID: PMC8328349
DOI: 10.1038/s41586-021-03718-6

Published Erratum

Publisher Correction: Global absence and targeting of protective immune states in severe COVID-19

Alexis J Combes et al. Nature. 2021 Aug.

. 2021 Aug;596(7872):E8.

doi: 10.1038/s41586-021-03718-6.

Authors

Collaborators

Affiliations

¹ Department of Pathology, University of California San Francisco, San Francisco, CA, USA. Alexis.Combes@ucsf.edu.
² ImmunoX Initiative, University of California San Francisco, San Francisco, CA, USA. Alexis.Combes@ucsf.edu.
³ UCSF CoLabs, University of California San Francisco, San Francisco, CA, USA. Alexis.Combes@ucsf.edu.
⁴ Department of Pathology, University of California San Francisco, San Francisco, CA, USA.
⁵ ImmunoX Initiative, University of California San Francisco, San Francisco, CA, USA.
⁶ UCSF CoLabs, University of California San Francisco, San Francisco, CA, USA.
⁷ Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
⁸ Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
⁹ Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.
¹⁰ Department of Otolaryngology, University of California San Francisco, San Francisco, CA, USA.
¹¹ Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.
¹² Sandler Asthma Basic Research Center, University of California San Francisco, San Francisco, CA, USA.
¹³ Institute for Human Genetics, University of California San Francisco, San Francisco, CA, USA.
¹⁴ Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
¹⁵ Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
¹⁶ Division of Infectious Disease, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
¹⁷ Division of Hospital Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
¹⁸ Department of Pathology, University of California San Francisco, San Francisco, CA, USA. ArjunArkal.Rao@ucsf.edu.
¹⁹ ImmunoX Initiative, University of California San Francisco, San Francisco, CA, USA. ArjunArkal.Rao@ucsf.edu.
²⁰ UCSF CoLabs, University of California San Francisco, San Francisco, CA, USA. ArjunArkal.Rao@ucsf.edu.
²¹ Department of Pathology, University of California San Francisco, San Francisco, CA, USA. Matthew.Krummel@ucsf.edu.
²² ImmunoX Initiative, University of California San Francisco, San Francisco, CA, USA. Matthew.Krummel@ucsf.edu.

^# Contributed equally.

PMID: 34341540
PMCID: PMC8328349
DOI: 10.1038/s41586-021-03718-6

No abstract available

PubMed Disclaimer

Erratum for

Global absence and targeting of protective immune states in severe COVID-19.
Combes AJ, Courau T, Kuhn NF, Hu KH, Ray A, Chen WS, Chew NW, Cleary SJ, Kushnoor D, Reeder GC, Shen A, Tsui J, Hiam-Galvez KJ, Muñoz-Sandoval P, Zhu WS, Lee DS, Sun Y, You R, Magnen M, Rodriguez L, Im KW, Serwas NK, Leligdowicz A, Zamecnik CR, Loudermilk RP, Wilson MR, Ye CJ, Fragiadakis GK, Looney MR, Chan V, Ward A, Carrillo S; UCSF COMET Consortium; Matthay M, Erle DJ, Woodruff PG, Langelier C, Kangelaris K, Hendrickson CM, Calfee C, Rao AA, Krummel MF. Combes AJ, et al. Nature. 2021 Mar;591(7848):124-130. doi: 10.1038/s41586-021-03234-7. Epub 2021 Jan 25. Nature. 2021. PMID: 33494096 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Publisher Correction: Global absence and targeting of protective immune states in severe COVID-19

Collaborators

Affiliations

Publisher Correction: Global absence and targeting of protective immune states in severe COVID-19

Authors

Collaborators

Affiliations

Erratum for

Similar articles

Publication types

LinkOut - more resources

Full Text Sources